At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Nov 9, 2026 at 16:39 ET
SOTERIA Precision Medicine Foundation announced a collaboration with Tempus to provide genomic sequencing and AI-enabled diagnostic support for precision oncology care to U.S. active-duty and veteran military populations. The partnership expands Tempus's platform into a new patient cohort but does not disclose any financial terms, revenue commitments, or volume guarantees.
- Collaboration with SOTERIA Precision Medicine Foundation, a non-profit, to deliver genomic profiling and AI diagnostics to military cancer patients
- No financial terms, contract value, or revenue commitments disclosed in the release
- Tempus's platform will support SOTERIA's Cancer Hunt initiative for active-duty and veteran populations
- Partnership is non-exclusive and no stated minimum volume or duration
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access